BATS BZX Real-Time Price
As of 1:35pm ET
| +0.06 / +3.26%|
The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +5.26% increase from the last price of 1.90.
The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.